Suchergebnisse - "Audisio, Marco"

PubPharm (29)

1

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021 : a meta-research study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Rossi, A. | Aimar, G. | Audisio, M. | +17

2

Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis

enthalten in: Tumori | 2023

von Turco, F. | Tucci, M. | Angusti, T. | +12

3

Therapeutic sequencing in advanced renal cell carcinoma : How to choose considering clinical and biological factors

enthalten in: Critical reviews in oncology/hematology | 2023

von Delcuratolo, M. | Tucci, M. | Turco, F. | +9

4

Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review

enthalten in: Seminars in oncology | 2022

von Persano, I. | Parlagreco, E. | La Salvia, A. | +5

5

Treatment intensification for metastatic prostate cancer : New treatment landscapes in androgen deprivation-based therapy

enthalten in: Cancer communications (London, England) | 2022

von Turco, F. | Tucci, M. | Delcuratolo, M. | +9

6

New emerging targets in advanced urothelial carcinoma : Is it the primetime for personalized medicine?

enthalten in: Critical reviews in oncology/hematology | 2022

von Audisio, M. | Tucci, M. | Di Stefano, R. | +9

7

Metastatic Urothelial Carcinoma : Have We Take the Road to the Personalized Medicine?

enthalten in: Cells | 2022

von Audisio, M. | Buttigliero, C. | Turco, F. | +9

8

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

enthalten in: Cancer immunology, immunotherapy : CII | 2022

von Russano, M. | Cortellini, A. | Giusti, R. | +47

9

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma

enthalten in: Critical reviews in oncology/hematology | 2022

von Tagliamento, M. | Bironzo, P. | Curcio, H. | +18

10

New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer : Immune Checkpoint Inhibitors and Beyond

enthalten in: Cells | 2022

von Audisio, A. | Buttigliero, C. | Delcuratolo, M. | +7